Product details & mandatory information
formoline L112 Extra in detail
Active ingredients:
- Poliglusam
Excipients:
- Silicon dioxide
- cellulose
- Magnesium stearate (vegetable)
- ascorbic acid
- tartaric acid
- Sodium sulphate (anhydrous)
formoline L112 Extra is a proven slimming product and lipid binder to support weight reduction, control and reduce calorie intake. It is particularly suitable for overweight people over 75 kg and contains 50% more of the active dietary fibre L112.
Application:
- For weight loss: take 2 tablets twice a day with a large glass of water with the two meals containing the most fat.
- For weight control: Take 1 tablet twice a day with plenty of liquid.
Advice:
- Fluid intake: Drink at least 2-3 litres of water daily to optimise the effect and support the transport of the tablets.
- Vitamin intake: To cover the need for fat-soluble vitamins and essential fatty acids, it is recommended to take formoline L112 only with 2 out of 3 main meals and to eat one meal a day with high-quality oils and fats.
Composition:
The main active ingredient is a ß-1,4-polymer of D-glucosamine and N-acetyl-D-glucosamine, obtained from crustacean shells, supplemented with vegetable cellulose, vitamin C, tartaric acid, silicon dioxide and vegetable magnesium stearate.
Additional information:
formoline L112 Extra contains no flavour enhancers, preservatives or colourings and is free from gelatine, lactose, cholesterol, gluten and milk protein, making it suitable for diabetics.
Advantages
- Reduces calorie intake by binding dietary fats in the gastrointestinal tract
- Clinically confirmed effect and multiple award-winning product for weight reduction
- High tolerability
Important notes
For risks and side effects, read the package leaflet and ask your doctor or pharmacist.
The seller reserves the right to carry out a pharmaceutical check by our pharmacists on the quantity of the medicine ordered. This may result in reductions in your order for this product. The invoice amount will then be adjusted automatically.
The reason for this is our pharmaceutical duty of care.
